Abbvie launching another upadacitinib phase 3 trial w/essentially zero preliinary data
I personally love this strategy; I think Phase 2's are an expensive waste of time
Better to go big and answer the question?
COI: I participate in SELECT-GCA
#ACR22 @RheumNow #Vasculitis22
I personally love this strategy; I think Phase 2's are an expensive waste of time
Better to go big and answer the question?
COI: I participate in SELECT-GCA
#ACR22 @RheumNow #Vasculitis22
